Bronstein A, Curcio H, Monnet I, Ricordel C, et al. Rebiopsy Feasibility and Clinical Impact on Metastatic Non-Small-Cell Lung Cancer With EGFR/ALK/ROS Oncogenic Driver Progression After Optimal Targeted Therapy: A Multicenter Real-World Analysis. Clin Lung Cancer 2025 Aug 21:S1525-7304(25)00198.
PMID: 40947344